California Public Employees Retirement System’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1M Buy
198,530
+9,129
+5% +$580K 0.01% 784
2025
Q4
$12M Buy
189,401
+39,002
+26% +$2.43M 0.01% 826
2025
Q3
$8.27M Buy
150,399
+7,797
+5% +$321K ﹤0.01% 966
2025
Q2
$4.71M Buy
142,602
+13,911
+11% +$484K ﹤0.01% 1049
2025
Q1
$5.17M Sell
128,691
-6,782
-5% -$312K ﹤0.01% 1028
2024
Q4
$6.37M Sell
135,473
-48,263
-26% -$2.51M ﹤0.01% 997
2024
Q3
$9.7M Buy
183,736
+3,999
+2% +$223K 0.01% 919
2024
Q2
$9.74M Buy
179,737
+48,596
+37% +$2.93M 0.01% 870
2024
Q1
$9.19M Sell
131,141
-4,580
-3% -$354K 0.01% 913
2023
Q4
$11.3M Hold
135,721
0.01% 823
2023
Q3
$4M Buy
135,721
+8,320
+7% +$277K ﹤0.01% 1115
2023
Q2
$4.16M Sell
127,401
-8,216
-6% -$304K ﹤0.01% 1114
2023
Q1
$4.77M Sell
135,617
-30,064
-18% -$1.23M ﹤0.01% 1087
2022
Q4
$7.59M Buy
165,681
+19,758
+14% +$850K 0.01% 995
2022
Q3
$7.07M Buy
+145,923
New +$7.02M 0.01% 1014
2021
Q2
Sell
-135,000
Closed -$3.14M 1914
2021
Q1
$3.14M Sell
135,000
-14,258
-10% -$304K ﹤0.01% 1719
2020
Q4
$3.1M Sell
149,258
-2,800
-2% -$51.2K ﹤0.01% 1716
2020
Q3
$3.29M Buy
152,058
+26,217
+21% +$613K ﹤0.01% 1521
2020
Q2
$2.97M Buy
125,841
+1,456
+1% +$27.3K ﹤0.01% 1552
2020
Q1
$1.47M Buy
124,385
+1,963
+2% +$25K ﹤0.01% 1779
2019
Q4
$1.3M Buy
122,422
+33,025
+37% +$339K ﹤0.01% 2241
2019
Q3
$1.02M Buy
89,397
+12,667
+17% +$159K ﹤0.01% 2269
2019
Q2
$863K Buy
76,730
+1,055
+1% +$10.2K ﹤0.01% 2242
2019
Q1
$612K Hold
75,675
﹤0.01% 2491
2018
Q4
$478K Hold
75,675
﹤0.01% 2570
2018
Q3
$745K Sell
75,675
-3,400
-4% -$27.3K ﹤0.01% 2491
2018
Q2
$656K Sell
79,075
-3,600
-4% -$30K ﹤0.01% 2535
2018
Q1
$595K Hold
82,675
﹤0.01% 2562
2017
Q4
$674K Hold
82,675
﹤0.01% 2525
2017
Q3
$1.2M Hold
82,675
﹤0.01% 2193
2017
Q2
$1M Hold
82,675
﹤0.01% 2271
2017
Q1
$1.06M Hold
82,675
﹤0.01% 2257
2016
Q4
$1M Hold
82,675
﹤0.01% 2311
2016
Q3
$759K Hold
82,675
﹤0.01% 2514
2016
Q2
$785K Hold
82,675
﹤0.01% 2494
2016
Q1
$583K Sell
82,675
-34,900
-30% -$255K ﹤0.01% 2650
2015
Q4
$1.23M Buy
117,575
+34,900
+42% +$342K ﹤0.01% 2252
2015
Q3
$553K Hold
82,675
﹤0.01% 2729
2015
Q2
$556K Sell
82,675
-29,300
-26% -$192K ﹤0.01% 2840
2015
Q1
$864K Hold
111,975
﹤0.01% 2678
2014
Q4
$864K Sell
111,975
-8,100
-7% -$34.8K ﹤0.01% 2678
2014
Q3
$423K Hold
120,075
﹤0.01% 3049
2014
Q2
$574K Buy
120,075
+42,000
+54% +$256K ﹤0.01% 2922
2014
Q1
$693K Buy
78,075
+21,500
+38% +$194K ﹤0.01% 2785
2013
Q4
$378K Sell
56,575
-1,000
-2% -$6.57K ﹤0.01% 3084
2013
Q3
$437K Buy
+57,575
New +$618K ﹤0.01% 2840

Other funds holding CYTK

California Public Employees Retirement System's CYTK Position: Q1 2026 in Review

California Public Employees Retirement System increased its Cytokinetics (CYTK) stake by 4.8% in Q1 2026, buying an estimated $580K and bringing the position to 198,530 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #784.

California Public Employees Retirement System first reported a position in CYTK in Q3 2013 and has held it in 46 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • California Public Employees Retirement System held 198,530 shares of Cytokinetics worth $13.1M as of Q1 2026.
  • California Public Employees Retirement System bought 9,129 Cytokinetics shares in Q1 2026, an estimated $580K.
  • Cytokinetics made up 0.01% of California Public Employees Retirement System's portfolio in Q1 2026, its #784 holding.
  • California Public Employees Retirement System first reported a position in Cytokinetics in Q3 2013 and has held it in 46 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.